Clint Mitchell

3.0k total citations
43 papers, 2.5k citations indexed

About

Clint Mitchell is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Clint Mitchell has authored 43 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 19 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Clint Mitchell's work include Cell death mechanisms and regulation (14 papers), Cancer-related Molecular Pathways (9 papers) and Sphingolipid Metabolism and Signaling (7 papers). Clint Mitchell is often cited by papers focused on Cell death mechanisms and regulation (14 papers), Cancer-related Molecular Pathways (9 papers) and Sphingolipid Metabolism and Signaling (7 papers). Clint Mitchell collaborates with scholars based in United States, Russia and Canada. Clint Mitchell's co-authors include Paul Dent, Steven Grant, Adly Yacoub, Margaret A. Park, Paul B. Fisher, Mohamed Rahmani, Sarah Spiegel, Aditi Pandya Martin, Elaine Studer and Youwen Fang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Clint Mitchell

43 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clint Mitchell United States 30 1.6k 846 528 347 245 43 2.5k
Józefa Węsierska‐Gądek Austria 30 1.3k 0.8× 1.2k 1.4× 505 1.0× 302 0.9× 169 0.7× 99 2.5k
Tyler Lahusen United States 25 1.7k 1.1× 1.3k 1.5× 533 1.0× 335 1.0× 229 0.9× 35 3.2k
Margaret A. Park United States 28 1.4k 0.9× 574 0.7× 513 1.0× 311 0.9× 310 1.3× 55 2.1k
José Palacios Spain 26 1.5k 0.9× 870 1.0× 365 0.7× 195 0.6× 290 1.2× 58 2.9k
Qihan Dong Australia 29 1.4k 0.9× 631 0.7× 377 0.7× 168 0.5× 191 0.8× 83 2.5k
Rieko Ohki Japan 21 2.3k 1.4× 1.2k 1.4× 266 0.5× 216 0.6× 194 0.8× 50 3.0k
Sabina Cosulich United Kingdom 26 2.0k 1.2× 526 0.6× 234 0.4× 207 0.6× 115 0.5× 55 2.6k
Nelofer Syed United Kingdom 27 2.2k 1.3× 1.2k 1.4× 828 1.6× 363 1.0× 307 1.3× 67 3.5k
Keren Paz United States 21 1.7k 1.1× 560 0.7× 233 0.4× 701 2.0× 112 0.5× 33 2.6k
Kathryn Balmanno United Kingdom 25 2.4k 1.5× 956 1.1× 277 0.5× 309 0.9× 94 0.4× 45 3.2k

Countries citing papers authored by Clint Mitchell

Since Specialization
Citations

This map shows the geographic impact of Clint Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clint Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clint Mitchell more than expected).

Fields of papers citing papers by Clint Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clint Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clint Mitchell. The network helps show where Clint Mitchell may publish in the future.

Co-authorship network of co-authors of Clint Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Clint Mitchell. A scholar is included among the top collaborators of Clint Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clint Mitchell. Clint Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lawrence, Christine, et al.. (2013). Progressive periodic hypothermia and bradycardia. British Journal of Hospital Medicine. 74(5). 292–293. 1 indexed citations
2.
Park, Margaret A., Clint Mitchell, Guo Zhang, et al.. (2010). Vorinostat and Sorafenib Increase CD95 Activation in Gastrointestinal Tumor Cells through a Ca2+- De novo Ceramide-PP2A-Reactive Oxygen Species–Dependent Signaling Pathway. Cancer Research. 70(15). 6313–6324. 86 indexed citations
3.
Yacoub, Adly, Hossein A. Hamed, Jeremy C. Allegood, et al.. (2010). PERK–Dependent Regulation of Ceramide Synthase 6 and Thioredoxin Play a Key Role in mda -7/IL-24–Induced Killing of Primary Human Glioblastoma Multiforme Cells. Cancer Research. 70(3). 1120–1129. 89 indexed citations
4.
Walker, Teneille, Clint Mitchell, Margaret A. Park, et al.. (2010). 17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca2+-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species. Molecular Cancer Therapeutics. 9(5). 1378–1395. 16 indexed citations
5.
Park, Margaret A., Hossein A. Hamed, Clint Mitchell, et al.. (2010). A Serotype 5/3 Adenovirus Expressing MDA-7/IL-24 Infects Renal Carcinoma Cells and Promotes Toxicity of Agents That Increase Ros and Ceramide Levels. Molecular Pharmacology. 79(3). 368–380. 22 indexed citations
6.
Kapitonov, Dmitri, Jeremy C. Allegood, Clint Mitchell, et al.. (2009). Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts. Cancer Research. 69(17). 6915–6923. 154 indexed citations
7.
Martin, Aditi Pandya, Clint Mitchell, Mohamed Rahmani, et al.. (2009). Inhibition of MCL-1 enhances Lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy. Cancer Biology & Therapy. 8(21). 2084–2096. 81 indexed citations
8.
Walker, Teneille, Clint Mitchell, Margaret A. Park, et al.. (2009). Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms. Molecular Pharmacology. 76(2). 342–355. 81 indexed citations
9.
Zhang, Guo, Margaret A. Park, Clint Mitchell, et al.. (2008). Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation. Clinical Cancer Research. 14(17). 5385–5399. 101 indexed citations
10.
11.
Park, Margaret A., Guo Zhang, Aditi Pandya Martin, et al.. (2008). Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biology & Therapy. 7(10). 1648–1662. 146 indexed citations
12.
Fang, Youwen, Elaine Studer, Clint Mitchell, et al.. (2007). Conjugated Bile Acids Regulate Hepatocyte Glycogen Synthase Activity In Vitro and In Vivo via Gαi Signaling. Molecular Pharmacology. 71(4). 1122–1128. 40 indexed citations
13.
Mitchell, Clint, Peyman Kabolizadeh, John Ryan, et al.. (2007). Low-Dose BBR3610 Toxicity in Colon Cancer Cells Is p53-Independent and Enhanced by Inhibition of Epidermal Growth Factor Receptor (ERBB1)-Phosphatidyl Inositol 3 Kinase Signaling. Molecular Pharmacology. 72(3). 704–714. 25 indexed citations
14.
Yacoub, Adly, Margaret A. Park, David E. Hanna, et al.. (2006). OSU-03012 Promotes Caspase-Independent but PERK-, Cathepsin B-, BID-, and AIF-Dependent Killing of Transformed Cells. Molecular Pharmacology. 70(2). 589–603. 66 indexed citations
15.
Dent, Paul, Youwen Fang, Seema Gupta, et al.. (2005). Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin–sensitive mechanism in murine and human hepatocytes†. Hepatology. 42(6). 1291–1299. 100 indexed citations
16.
Carón, Rubén W., Adly Yacoub, Clint Mitchell, et al.. (2005). Radiation-Stimulated ERK1/2 and JNK1/2 Signaling can Promote Cell Cycle Progression in Human Colon Cancer Cells. Cell Cycle. 4(3). 456–464. 21 indexed citations
17.
Yacoub, Adly, Clint Mitchell, Young Ki Hong, et al.. (2004). MDA-7 regulates cell growth and radiosensitivity in vitro of primary (Non-Established) human glioma cells. Cancer Biology & Therapy. 3(8). 739–751. 70 indexed citations
18.
Yacoub, Adly, Clint Mitchell, Elizabeth Rosenberg, et al.. (2003). MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacity.. PubMed. 2(7). 623–32. 49 indexed citations
19.
Yacoub, Adly, Clint Mitchell, Irina V. Lebedeva, et al.. (2003). Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo.. PubMed. 9(9). 3272–81. 48 indexed citations
20.
Yacoub, Adly, Clint Mitchell, Irina V. Lebedeva, et al.. (2003). mda-7(IL-24) Inhibits Growth and Enhances Radiosensitivity of Glioma Cells In Vitro via JNK Signaling. Cancer Biology & Therapy. 2(4). 347–353. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Józefa Węsierska‐Gądek Breakdown of academic impact, for papers by Tyler Lahusen Breakdown of academic impact, for papers by Margaret A. Park Breakdown of academic impact, for papers by José Palacios Breakdown of academic impact, for papers by Qihan Dong Breakdown of academic impact, for papers by Rieko Ohki Breakdown of academic impact, for papers by Sabina Cosulich Breakdown of academic impact, for papers by Nelofer Syed Breakdown of academic impact, for papers by Keren Paz Breakdown of academic impact, for papers by Kathryn Balmanno
Rankless by CCL
2026